Frontlight ResearchEarly access
Ankylosing spondylitis trials in Brazil
1 of 1 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 4Taking peopleSafety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
- Where
- São Paulo
- Age
- 12 years to 59 years
- People
- 477
- Run by
- University of Sao Paulo General Hospital
See details and how to joinNCT07087912